Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children

Fig. 3

This is the CONSORT diagram showing the process whereby 393 perinatally HIV-unexposed and uninfected children (HUU) at 5–6 months of age were enrolled in a randomized controlled trial (RCT) to evaluate the effects of four different malaria chemoprevention treatment arms on incidence of malaria illness and levels of anaemia. At 2 years of age, these children malaria chemoprevention was discontinued and children co-enrolled in the present study (N = 325) were evaluated with the Mullen Scales of Early Learning (MSEL). All RCT children continued to be monitored for malaria illness and anaemia until 3 years of age, at which time remaining eligible children were again evaluated with the MSEL along with those co-enrolled between 2 and 3 years who were missed at the earlier 2-year of age assessment (N = 331)

Back to article page